496 related articles for article (PubMed ID: 31927006)
21. m
Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
[TBL] [Abstract][Full Text] [Related]
22. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
[TBL] [Abstract][Full Text] [Related]
23. The demethylase ALKBH5 mediates ZKSCAN3 expression through the m
Wang Q; Huang Y; Jiang M; Tang Y; Wang Q; Bai L; Yu C; Yang X; Ding K; Wang W; Bai J; Chen Y
J Hazard Mater; 2024 Jul; 473():134690. PubMed ID: 38781857
[TBL] [Abstract][Full Text] [Related]
24. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
25. ALKBH5-m
Chao Y; Shang J; Ji W
Biochem Biophys Res Commun; 2020 Jan; 521(2):499-506. PubMed ID: 31677788
[TBL] [Abstract][Full Text] [Related]
26. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
Gong H; Liu L; Cui L; Ma H; Shen L
Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
[TBL] [Abstract][Full Text] [Related]
27. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
[TBL] [Abstract][Full Text] [Related]
28. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1.
Zhang J; Guo S; Piao HY; Wang Y; Wu Y; Meng XY; Yang D; Zheng ZC; Zhao Y
J Physiol Biochem; 2019 Aug; 75(3):379-389. PubMed ID: 31290116
[TBL] [Abstract][Full Text] [Related]
29. m
Xue L; Li J; Lin Y; Liu D; Yang Q; Jian J; Peng J
J Cell Physiol; 2021 Apr; 236(4):2649-2658. PubMed ID: 32892348
[TBL] [Abstract][Full Text] [Related]
30. LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m
Fang Y; Wu X; Gu Y; Shi R; Yu T; Pan Y; Zhang J; Jing X; Ma P; Shu Y
Clin Transl Med; 2023 Mar; 13(3):e1205. PubMed ID: 36864711
[TBL] [Abstract][Full Text] [Related]
31. M
Qiu X; Yang S; Wang S; Wu J; Zheng B; Wang K; Shen S; Jeong S; Li Z; Zhu Y; Wu T; Wu X; Wu R; Liu W; Wang HY; Chen L
Cancer Res; 2021 Sep; 81(18):4778-4793. PubMed ID: 34301762
[TBL] [Abstract][Full Text] [Related]
32. A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles.
Cao L; Han R; Zhao Y; Qin X; Li Q; Xiong H; Kong Y; Liu Z; Li Z; Dong F; Li T; Zhao X; Lei L; Zhao Q; Liu D; Wang B; Wu X
Cell Rep; 2024 Apr; 43(4):114032. PubMed ID: 38568805
[TBL] [Abstract][Full Text] [Related]
33. FTSJ1 regulates tRNA 2'-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression.
He Q; Yang L; Gao K; Ding P; Chen Q; Xiong J; Yang W; Song Y; Wang L; Wang Y; Ling L; Wu W; Yan J; Zou P; Chen Y; Zhai R
Cell Death Dis; 2020 May; 11(5):348. PubMed ID: 32393790
[TBL] [Abstract][Full Text] [Related]
34. Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5.
Zhu K; Gou F; Zhao Z; Xu K; Song J; Jiang H; Zhang F; Yang Y; Li J
Leuk Res; 2024 Jun; 141():107451. PubMed ID: 38663164
[TBL] [Abstract][Full Text] [Related]
35. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
36. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
Zhang L; Su X
Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
[TBL] [Abstract][Full Text] [Related]
37. The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.
Feng L; Fan Y; Zhou J; Li S; Zhang X
FEBS Lett; 2021 Aug; 595(15):2007-2014. PubMed ID: 34105773
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
39. K235 acetylation couples with PSPC1 to regulate the m
Zhang XL; Chen XH; Xu B; Chen M; Zhu S; Meng N; Wang JZ; Zhu H; Chen D; Liu JB; Yan GR
Nat Commun; 2023 Jun; 14(1):3815. PubMed ID: 37369679
[TBL] [Abstract][Full Text] [Related]
40. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]